Answers are grounded in this paper and cite their sources.
Catecholamines may stimulate ACTH secretion during stress. To investigate the nature and site of such an action, plasma ACTH was measured in four groups of unanesthetized adult female rats with an indwelling carotid cannula. Sequential 300-μ1 blood samples were taken 60 min, 30 min, and immediately before an intracerebroventricular (icv) infusion of 2.5 μl adrenaline or noradrenaline and 5,15, 45, 60, and 120 min after the infusion. The four groups were: 1) intact rats; 2) rats infused 7 days after undergoing a discrete bilateral lesion of the ventral noradrenergic ascending bundle caused by 6-hydroxydopamine, which depleted their hypothalamic adrenaline and noradrenaline levels by 90% and 80%, respectively; 3) rats infused 30 min after pretreatment via the icv route with either prazosin or propranolol; and 4) rats infused 16 and 2 h after two successive intracarotid injections of an anti-rCRH-41 serum. In another group, the effects of icv catecholamine administration were compared with those of an intracerebral (ic) microinfusion close to a single paraventricular nucleus (PVN). Finally, in two additional groups blood was sampled at the above-mentioned times before and after a 2-min ether inhalation by intact rats or prazosin- and/or propranolol-pretreated rats. In the intact rats (group 1), a stress-like stimulatory dose response was noted after both adrenaline and noradrenaline infusions, with a half-maximal effect at concentrations of about 0.6 nmol and a maximal effect at 2.7 nmol or more. At maximally effective doses, adrenaline was significantly more active than noradrenaline. In the rats with ventral noradrenergic ascending bundle lesions (group 2), 2.7 nM adrenaline or noradrenaline stimulated ACTH release as in the controls without lesions. In group 3, prazosin blocked the ACTH responses to both adrenaline and noradrenaline, whereas propranolol only blocked the response to adrenaline. In group 4, i.e. rats pretreated with an anti-rCRH-41 serum, the amplitude of the ACTH surge after icv adrenaline or noradrenaline infusion was halved. A unilateral ic catecholamine microinfusion next to the PVN (half the icv dose given in group 1) led to a rapid ACTH release that peaked at half the response measured in the icv infused rats. Ether stress-induced ACTH release was decreased by 50-60% after icv pretreatment with 1 or 10 μg prazosin, 1 or 6.5 μg propranolol, or a combined dose comprising 1 pg of both. The following conclusions were reached. 1) Intracerebroventricularly infused adrenaline, acting via α1and β-receptors, or noradrenaline acting via β-receptors, induced stress-like ACTH surges in both intact rats and rats whose endogenous hypothalamic catecholamines had been depleted by a selective neurotoxic denervation. 2) The implication of CRHsecreting neurons in these ACTH surges is suggested by the dramatically decreased response in rats immunoneutralized with an anti-rCRH-41 serum and by the similar efficacy of catecholamines administrated either by ic infusion close to the PVN or via the icv route. 3) In light of these results, the comparable inhibition of an ether stress-induced ACTH surge by icv injections of α1- and/or β-blockers suggests that a stimulatory and centrally located mechanism involving adrenaline and perhaps noradrenaline may be an essential component of the ACTH response to stress. 4) Moreover, comparison of simultaneous ACTH and corticosterone release in these experiments confirmed that the large amount of ACTH released under stress by far exceeds the capacity of the adrenal hormones to respond to ACTH stimulation. (Endocrinology121: 883–892,1987)
No takes yet. Share an insight, caveat, or question.
Szafarczyk et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: